What You Should Know:
- RedHill Biopharma, a specialty biopharmaceutical company, and ObvioHealth, a global virtual research organization, have partnered on the largest remote clinical study for a new at-home COVID-19 treatment, Upamostat.
- The trial is being performed completely remotely in patients’ homes using ObvioHealth’s clinical trial ecosystem including digital devices, a patient-centric smartphone application and home healthcare visits.
- The randomized, double-blind,
Read More
biopharmaceutical
AliveCor, AstraZeneca Partner to Screen for Blood Potassium Levels Via Electrocardiograms
What You Should Know:
- AliveCor, a digital AI-based personal technology provider, and AstraZeneca, a global leader in the biopharmaceutical space, are working together to create more informed disease management solutions across cardiovascular, renal, and metabolism therapeutic areas.
- The collaboration will focus on the development of AliveCor’s potassium detection technology through their Kardia-K AI platform, to screen for elevated levels of blood potassium via electrocardiograms.
Read More
Why Cancer Registries are Part of America’s Fight for Racial Equality
According to a 2019 study in the Proceedings of the National Academy of Sciences, one in 1,000 Black males can expect to die at the hands of the police. Black males were also 2.5 times more likely to die during an encounter with police than white males. For some, those figures are staggering. For many others, they are reminders of the racial disparities that have existed for far too long in this country.
So, in 2020, when recent events have brought racial injustice back into the national
Read More
Syapse Lands $68M to Expand Global Precision Oncology Data Sharing Network
What You Should Know:
- Syapse raises 68M in equity investment led by Ally Bridge Group (ABG), with Northpond Ventures to expand delivery of real-world evidence through Syapse’s Learning Health Network.
- The Syapse Learning Health Network is a global precision oncology data sharing network, improving cancer care across communities by using real-world data to support clinical decisions.
Syapse, a San Francisco, CA-based real-world evidence company accelerating the delivery
Read More
Why A Patient-First Strategy for Specialty Rx Pharmacists Is Critical to Optimize Outcomes
One of the biggest challenges for biopharmaceutical companies of rare and orphan disease patient populations is optimizing disease management in a way that enhances the patient journey and improves outcomes. As these companies seek innovative solution partners, a patient-first approach that offers specialty Rx pharmacist expertise is critical for securing insurance coverage, coordinating care, ensuring compliance, and, ultimately, minimizing the daily impact of rare and orphan
Read More
OurCrowd Launches $100M Pandemic Innovation Fund to Invest in Companies on Front Lines of COVID-19
What You Should Know:
- Israeli venture capital platform OurCrowd launches $100M Pandemic Fund to invest in companies on the front lines of COVID-19.
- The fund plans to raise $100M to invest in 15-20 companies focused on prevention & containment, treatment & healing, and community & disruption mitigation technology solutions to combat current and future pandemic.
OurCrowd,
a Jerusalem, Israel-based crowdfunded-venture investment platform, today
announced the launch of
Read More
Corrona Acquires Patient Experience Company HealthiVibe
- Corrona acquires patient experience company HealthiVibe to further expand its presence in the patient experience marketplace. - HealthiVibe uses a systematic, evidence-based process to help pharmaceutical clients spearhead patient engagement initiatives at every stage of the product lifecycle.Corrona, LLC, a provider of real-world observational and syndicated registry data, announced today that it has acquired HealthiVibe, LLC, an Arlington, VA-based patient experience company. Financial
Read More
ConvergeHEALTH by Deloitte Launches New Digital Health Ecosystem Platforms
- ConvergeHEALTH MyPATH for Health and MyPATH for Connected Care help enhance the patient experience, improve adherence and generate a rich, longitudinal, real-world data set for insights.Today at HLTH 2019, ConvergeHEALTH by Deloitte announced the launch of a robust platform for the healthcare ecosystem that supports two critically important patient journeys. MyPATH for Health and MyPATH for Connected Care work together to connect and support patients and their care teams across the patient
Read More
MyHealthTeams Lands $9.44M to Expand Social Networks for Chronic Condition Communities
MyHealthTeams, a San Francisco, CA-based creator of the largest and fastest-growing social networks for people facing chronic health conditions raised $9.44 million in a Series B financing round led by strategic investor UCB, a global biopharmaceutical company. This financing brings total investment in MyHealthTeams to $26.84M, building on the company's Seed and Series A1, A2 and A3 rounds. Existing investors including Adams Street Partners, Qiming US Ventures, CVS Health, The Westly Group,
Read More
IBM, KPMG, Merck and Walmart to Launch FDA Blockchain Pilot Program
IBM, KPMG, Merck, and Walmart today announced that the companies have been selected by the United States Food and Drug Administration (FDA) to be included in a blockchain pilot program in support of the U.S. Drug Supply Chain Security Act (DSCSA) that addresses requirements to identify, track and trace prescription medicines and vaccines distributed within the United States.Pilot Program OverviewThe FDA pilot program is intended to evaluate the use of blockchain technology to assist drug supply
Read More
